Inventor
WANG JIABING
CN30 patents
⚠️ This page may combine multiple inventors who share the name “WANG JIABING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
11 patentsUS6017926AJan 25, 2000
Integrin receptor antagonists
MERCK & CO INC108 citations98
US6048861AApr 11, 2000
Integrin receptor antagonists
MERCK & CO INC100 citations97
US7056909B2Jun 6, 2006
Alpha v integrin receptor antagonists
MERCK & CO INC21 citations92
US6784190B2Aug 31, 2004
Integrin receptor antagonists
MERCK & CO INC17 citations92
US6472403B2Oct 29, 2002
αV integrin receptor antagonists
MERCK & CO INC20 citations84
US7268153B2Sep 11, 2007
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
MERCK & CO INC14 citations82
US7629367B2Dec 8, 2009
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
MERCK & CO INC1 citations60
US7109191B2Sep 19, 2006
Benzazepinone alpha vintegrin receptor antagonists
MERCK & CO INC0 citations52
US7482359B2Jan 27, 2009
Androgen receptor modulators
MERCK & CO INC0 citations41
US7402577B2Jul 22, 2008
Androstane 17-beta-carboxamides as androgen receptor modulators
MERCK & CO INC0 citations41
US7625919B2Dec 1, 2009
4-azasteroid derivatives as androgen receptor modulators
MERCK & CO INC0 citations38
BETTA PHARMACEUTICALS CO LTD
7 patentsUS11365196B2Jun 21, 2022
FGFR inhibitor and application thereof
BETTA PHARMACEUTICALS CO LTD6 citations72
US11845762B2Dec 19, 2023
Compound functioning as bromodomain protein inhibitor, and composition
BETTA PHARMACEUTICALS CO LTD0 citations61
US11466034B2Oct 11, 2022
Compound functioning as bromodomain protein inhibitor, and composition
BETTA PHARMACEUTICALS CO LTD0 citations61
US12043622B2Jul 23, 2024
Crystal form of compound for inhibiting the activity of CDK4/6 and use thereof
BETTA PHARMACEUTICALS CO LTD0 citations59
US11053238B2Jul 6, 2021
Benzimidazole derivatives, preparation methods and uses thereof
BETTA PHARMACEUTICALS CO LTD1 citations59
US12187713B2Jan 7, 2025
Immunomodulators, compositions and methods thereof
BETTA PHARMACEUTICALS CO LTD0 citations48
US11466013B2Oct 11, 2022
ERK inhibitor and use thereof
BETTA PHARMACEUTICALS CO LTD0 citations39
ASTRAZENECA AB
3 patentsUS9375432B2Jun 28, 2016
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
ASTRAZENECA AB1 citations60
US9066979B2Jun 30, 2015
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
ASTRAZENECA AB3 citations60
US9718806B2Aug 1, 2017
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
ASTRAZENECA AB0 citations50